Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 27, 2021
Patent Application Number
15925182
Date Filed
March 19, 2018
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to Chimeric Antigen Receptors (CAR) that are recombinant chimeric proteins able to redirect immune cell specificity and reactivity toward selected membrane antigens, and more particularly in which extracellular ligand binding is a scFV derived from a CD123 monoclonal antibody, conferring specific immunity against CD123 positive cells. The engineered immune cells endowed with such CARs are particularly suited for treating lymphomas and leukemia.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
